% alzhub.org library filter % Source: https://alzhub.org/research?author=McClean+PL&atag=glp-1 % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{mcclean2014-23973293, author = {McClean, P. L. and Hölscher, C.}, title = {{Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease}}, journal = {Neuropharmacology}, year = {2014}, doi = {10.1016/j.neuropharm.2013.08.005}, pmid = {23973293}, url = {https://doi.org/10.1016/j.neuropharm.2013.08.005} } @article{denver2018-29604345, author = {Denver, P. and English, A. and McClean, P. L.}, title = {{Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice}}, journal = {Brain, behavior, and immunity}, year = {2018}, doi = {10.1016/j.bbi.2018.03.032}, pmid = {29604345}, url = {https://doi.org/10.1016/j.bbi.2018.03.032} } @article{mcclean2010-20035739, author = {McClean, P. L. and Gault, V. A. and Harriott, P. and Hölscher, C.}, title = {{Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease}}, journal = {European journal of pharmacology}, year = {2010}, doi = {10.1016/j.ejphar.2009.12.023}, pmid = {20035739}, url = {https://doi.org/10.1016/j.ejphar.2009.12.023} } @article{mcclean2014-25107586, author = {McClean, P. L. and Hölscher, C.}, title = {{Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease}}, journal = {Neuropharmacology}, year = {2014}, doi = {10.1016/j.neuropharm.2014.07.015}, pmid = {25107586}, url = {https://doi.org/10.1016/j.neuropharm.2014.07.015} } @article{gengler2012-20359773, author = {Gengler, S. and McClean, P. L. and McCurtin, R. and Gault, V. A. and Hölscher, C.}, title = {{Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice}}, journal = {Neurobiology of aging}, year = {2012}, doi = {10.1016/j.neurobiolaging.2010.02.014}, pmid = {20359773}, url = {https://doi.org/10.1016/j.neurobiolaging.2010.02.014} } @article{longsmith2013-23011726, author = {Long-Smith, C. M. and Manning, S. and McClean, P. L. and Coakley, M. F. and O'Halloran, D. J. and Holscher, C. and O'Neill, C.}, title = {{The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease}}, journal = {Neuromolecular medicine}, year = {2013}, doi = {10.1007/s12017-012-8199-5}, pmid = {23011726}, url = {https://doi.org/10.1007/s12017-012-8199-5} } @article{mcclean2015-26205827, author = {McClean, P. L. and Jalewa, J. and Hölscher, C.}, title = {{Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice}}, journal = {Behavioural brain research}, year = {2015}, doi = {10.1016/j.bbr.2015.07.024}, pmid = {26205827}, url = {https://doi.org/10.1016/j.bbr.2015.07.024} }